Ikebuchi Yuki

イケブチユウキ | Ikebuchi Yuki

Research theme for competitive and other funds (8)：

2022 - 2026 Comprehensive analysis on Wnt signaling pathway to develop a novel signal modifier
2022 - 2025 Analysis of the roles of RANKL reverse signaling in the autoimmune disease development
2021 - 2025 Functional analysis of osteocytic membrane vesicles in osteoclast activation under daily activities
2021 - 2023 Analysis on the regulatory mechanism of bone remodeling based on cellular senescence in osteocytes
2018 - 2022 Optimization for usage of molecular targeted drugs on cancer therapy

Show all

Papers (15)：

ｍore...

MISC (27)：

Masashi Honma, Yuki Ikebuchi, Hiroshi Suzuki. RANKL as a key figure in bridging between the bone and immune system: Its physiological functions and potential as a pharmacological target. Pharmacology and Therapeutics. 2021. 218
Masashi Honma, Yuki Ikebuchi, Hiroshi Suzuki. Mechanisms of RANKL delivery to the osteoclast precursor cell surface. Journal of Bone and Mineral Metabolism. 2021. 39. 1. 27-33
曽根絵梨, 田村幸彦, 菅森泰隆, 依田哲也, 青木和広, 能代大輔, 本間雅, 池淵祐樹. 細胞膜上RANKL分子のクラスター化誘導による骨芽細胞分化促進作用. Journal of Oral Biosciences Supplement. 2018. 2018. 340-340
曽根絵梨, MASUD Khan, 能代大輔, 池淵祐樹, 本間雅, 田村幸彦, 菅森泰隆, 鈴木洋史, 宇田川信之, 青木和広. RANKL結合ペプチドによる骨形成促進メカニズムの検討. 日本骨形態計測学会雑誌. 2018. 28. 2. S158-S158
藏田玲美, 本間雅, 池淵祐樹, 苅谷嘉顕, 鈴木洋史. 関節リウマチに対する新規バイオロジクスの創製検討. 日本薬剤学会年会講演要旨集. 2018. 33年会. 168-168

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page